We use cookies to ensure that our site works correctly and provides you with the best experience. If you continue using our site without changing your browser settings, we'll assume that you agree to our use of cookies. Find out more about the cookies we use and how to manage them by reading our cookies policy. Hide

Current Issue

11th September 2018
Selected Chemistry & Industry magazine issue

Select an Issue

C&I

C&I e-books

C&I e-books

C&I apps

iOS App
Android App

Issue62018_Asphalt not trashphalt Asphalt not 'trashphalt'

News

006 Test tubes in lab web

Affordable drugs, faster

Anthony King, September 2018

Many pharma companies work on the same drug targets in parallel and in secret, which creates enormous duplication and waste of resources.

Feature

018 Nano futures web 2

Nano Futures

Victoria Hattersley, September 2018

From monitoring our heart rate and generating renewable energy to keeping astronauts safe in space, a number of novel applications for carbon nanotubes have emerged in recent months, Victoria Hattersley reports.

Webinars

Product Focus

Metrohm Product Focus

Postcards

There are no postcards for the issue of C&I Magazine which you have selected.

Click here to see other postcards from our international correspondents.

International Youth DayAugust 15, 2016

People

Movers and Shakers

September 2018

US biopharma company Acceleron Pharma, based in Cambridge, MA, has appointed Robert K. Zeldin as CMO.

Highlights

Biomedical

Kevin Burgess, September 2018

Abnormal protein homeostasis is implicated in many diseases including cancer.

Comment

Elementary analysis

Nikki Schopp, September 2018

Drug manufacturers must ensure their drugs are effective and safe. But there is more to consider than clinical trials.

Reviews

A comprehensive review

Simon Cotton, September 2018

A textbook that is in its sixth edition may reasonably be termed a classic.

Leader

Fake pharma

Neil Eisberg, September 2018

As well as preparing for all the different potential Brexit outcomes, including the move of the European Medicines Agency from London to Amsterdam, the European pharma sector is also facing the implementation of the EU Falsified Medicine Directive within the next few months.

Business

Business digest

September 2018

UK biotechnology company Albumedix has entered into a collaborative agreement with Novartis.

Global View

Clean costs

Sarah Houlton, September 2018

Obama’s Clean Power Plan has been scrapped. ACE, its replacement, is described as a more ‘affordable’ alternative.

Analysis

Measuring Up

Neil Eisberg, September 2018

A key aspect in the development of personalised medicine is measurement and analytical technologies. Neil Eisberg highlights the latest analytical instrumentation on show at PittCon 2018 in Orlando, Florida, US.